Prostate Cancer | Norton Healthcare

Indication: Prostate Cancer

A Phase 1b Study Evaluating the Safety and Efficacy of Multiple Therapies in Subjects With Metastatic Castration Resistant Prostate Cancer

Sub-indication: Genitourinary Cancer

Study Type: Drug Study

Principal Investigator: Joseph Maly, M.D.
Norton Cancer Institute

Sponsor: Sponsor: Amgen

Learn more at ClinicalTrials.gov

Email for more information: MISC-NCIResearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.